# Docetaxel

NDC: 45963-765
Generic name: Docetaxel
Labeler / Manufacturer: Actavis Pharma, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: INJECTION, SOLUTION, CONCENTRATE
Routes: INTRAVENOUS
Marketing started: 20140901

FDA application: NDA203551

## Active ingredients

- DOCETAXEL: 20 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"45963-765"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=45963-765
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=2c806400-5fdc-4398-8475-37f700b3191f